世界のドラッグリプロファイリング市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Drug Reprofiling Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1991
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ドラッグリプロファイリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ドラッグリプロファイリングの市場動向
・企業の競争状況、市場シェア
・ドラッグリプロファイリングの種類別市場規模（経口、静脈内）
・ドラッグリプロファイリングの用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）
・ドラッグリプロファイリングの北米市場規模2016-2027（アメリカ、カナダ）
・ドラッグリプロファイリングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ドラッグリプロファイリングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ドラッグリプロファイリングの中南米市場規模2016-2027（メキシコ、ブラジル）
・ドラッグリプロファイリングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis AG、Abbott Healthcare、Pfizer、Johnson & Johnson、Hoffmann-La Roche、Sandoz、Mylan Inc.、Teva Pharmaceuticals）
・結論

Market Analysis and Insights: Global Drug Reprofiling Market
The global Drug Reprofiling market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Reprofiling market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Reprofiling market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Reprofiling market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Reprofiling market.

Global Drug Reprofiling Scope and Market Size
Drug Reprofiling market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Reprofiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Orally
Intravenously

Segment by Application
Central Nervous Disorders
Cardiovascular Disorders
Oncology
others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Abbott Healthcare
Pfizer
Johnson & Johnson
Hoffmann-La Roche
Sandoz

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Reprofiling Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Orally
1.2.3 Intravenously
1.3 Market by Application
1.3.1 Global Drug Reprofiling Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Central Nervous Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Oncology
1.3.5 others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Reprofiling Market Perspective (2016-2027)
2.2 Drug Reprofiling Growth Trends by Regions
2.2.1 Drug Reprofiling Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Reprofiling Historic Market Share by Regions (2016-2021)
2.2.3 Drug Reprofiling Forecasted Market Size by Regions (2022-2027)
2.3 Drug Reprofiling Industry Dynamic
2.3.1 Drug Reprofiling Market Trends
2.3.2 Drug Reprofiling Market Drivers
2.3.3 Drug Reprofiling Market Challenges
2.3.4 Drug Reprofiling Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Reprofiling Players by Revenue
3.1.1 Global Top Drug Reprofiling Players by Revenue (2016-2021)
3.1.2 Global Drug Reprofiling Revenue Market Share by Players (2016-2021)
3.2 Global Drug Reprofiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Reprofiling Revenue
3.4 Global Drug Reprofiling Market Concentration Ratio
3.4.1 Global Drug Reprofiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Reprofiling Revenue in 2020
3.5 Drug Reprofiling Key Players Head office and Area Served
3.6 Key Players Drug Reprofiling Product Solution and Service
3.7 Date of Enter into Drug Reprofiling Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Reprofiling Breakdown Data by Type
4.1 Global Drug Reprofiling Historic Market Size by Type (2016-2021)
4.2 Global Drug Reprofiling Forecasted Market Size by Type (2022-2027)

5 Drug Reprofiling Breakdown Data by Application
5.1 Global Drug Reprofiling Historic Market Size by Application (2016-2021)
5.2 Global Drug Reprofiling Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Reprofiling Market Size (2016-2027)
6.2 North America Drug Reprofiling Market Size by Type
6.2.1 North America Drug Reprofiling Market Size by Type (2016-2021)
6.2.2 North America Drug Reprofiling Market Size by Type (2022-2027)
6.2.3 North America Drug Reprofiling Market Size by Type (2016-2027)
6.3 North America Drug Reprofiling Market Size by Application
6.3.1 North America Drug Reprofiling Market Size by Application (2016-2021)
6.3.2 North America Drug Reprofiling Market Size by Application (2022-2027)
6.3.3 North America Drug Reprofiling Market Size by Application (2016-2027)
6.4 North America Drug Reprofiling Market Size by Country
6.4.1 North America Drug Reprofiling Market Size by Country (2016-2021)
6.4.2 North America Drug Reprofiling Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Drug Reprofiling Market Size (2016-2027)
7.2 Europe Drug Reprofiling Market Size by Type
7.2.1 Europe Drug Reprofiling Market Size by Type (2016-2021)
7.2.2 Europe Drug Reprofiling Market Size by Type (2022-2027)
7.2.3 Europe Drug Reprofiling Market Size by Type (2016-2027)
7.3 Europe Drug Reprofiling Market Size by Application
7.3.1 Europe Drug Reprofiling Market Size by Application (2016-2021)
7.3.2 Europe Drug Reprofiling Market Size by Application (2022-2027)
7.3.3 Europe Drug Reprofiling Market Size by Application (2016-2027)
7.4 Europe Drug Reprofiling Market Size by Country
7.4.1 Europe Drug Reprofiling Market Size by Country (2016-2021)
7.4.2 Europe Drug Reprofiling Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Reprofiling Market Size (2016-2027)
8.2 Asia-Pacific Drug Reprofiling Market Size by Type
8.2.1 Asia-Pacific Drug Reprofiling Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Reprofiling Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Reprofiling Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Reprofiling Market Size by Application
8.3.1 Asia-Pacific Drug Reprofiling Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Reprofiling Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Reprofiling Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Reprofiling Market Size by Region
8.4.1 Asia-Pacific Drug Reprofiling Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Reprofiling Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Reprofiling Market Size (2016-2027)
9.2 Latin America Drug Reprofiling Market Size by Type
9.2.1 Latin America Drug Reprofiling Market Size by Type (2016-2021)
9.2.2 Latin America Drug Reprofiling Market Size by Type (2022-2027)
9.2.3 Latin America Drug Reprofiling Market Size by Type (2016-2027)
9.3 Latin America Drug Reprofiling Market Size by Application
9.3.1 Latin America Drug Reprofiling Market Size by Application (2016-2021)
9.3.2 Latin America Drug Reprofiling Market Size by Application (2022-2027)
9.3.3 Latin America Drug Reprofiling Market Size by Application (2016-2027)
9.4 Latin America Drug Reprofiling Market Size by Country
9.4.1 Latin America Drug Reprofiling Market Size by Country (2016-2021)
9.4.2 Latin America Drug Reprofiling Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Reprofiling Market Size (2016-2027)
10.2 Middle East & Africa Drug Reprofiling Market Size by Type
10.2.1 Middle East & Africa Drug Reprofiling Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Reprofiling Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Reprofiling Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Reprofiling Market Size by Application
10.3.1 Middle East & Africa Drug Reprofiling Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Reprofiling Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Reprofiling Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Reprofiling Market Size by Country
10.4.1 Middle East & Africa Drug Reprofiling Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Reprofiling Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Drug Reprofiling Introduction
11.1.4 Novartis AG Revenue in Drug Reprofiling Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Details
11.2.2 Abbott Healthcare Business Overview
11.2.3 Abbott Healthcare Drug Reprofiling Introduction
11.2.4 Abbott Healthcare Revenue in Drug Reprofiling Business (2016-2021)
11.2.5 Abbott Healthcare Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Drug Reprofiling Introduction
11.3.4 Pfizer Revenue in Drug Reprofiling Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Reprofiling Introduction
11.4.4 Johnson & Johnson Revenue in Drug Reprofiling Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Hoffmann-La Roche
11.5.1 Hoffmann-La Roche Company Details
11.5.2 Hoffmann-La Roche Business Overview
11.5.3 Hoffmann-La Roche Drug Reprofiling Introduction
11.5.4 Hoffmann-La Roche Revenue in Drug Reprofiling Business (2016-2021)
11.5.5 Hoffmann-La Roche Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Drug Reprofiling Introduction
11.6.4 Sandoz Revenue in Drug Reprofiling Business (2016-2021)
11.6.5 Sandoz Recent Development
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Details
11.7.2 Mylan Inc. Business Overview
11.7.3 Mylan Inc. Drug Reprofiling Introduction
11.7.4 Mylan Inc. Revenue in Drug Reprofiling Business (2016-2021)
11.7.5 Mylan Inc. Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Reprofiling Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Reprofiling Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drug Reprofiling Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Orally
Table 3. Key Players of Intravenously
Table 4. Global Drug Reprofiling Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Drug Reprofiling Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drug Reprofiling Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Drug Reprofiling Market Share by Regions (2016-2021)
Table 8. Global Drug Reprofiling Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Drug Reprofiling Market Share by Regions (2022-2027)
Table 10. Drug Reprofiling Market Trends
Table 11. Drug Reprofiling Market Drivers
Table 12. Drug Reprofiling Market Challenges
Table 13. Drug Reprofiling Market Restraints
Table 14. Global Drug Reprofiling Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Drug Reprofiling Market Share by Players (2016-2021)
Table 16. Global Top Drug Reprofiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Reprofiling as of 2020)
Table 17. Ranking of Global Top Drug Reprofiling Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Drug Reprofiling Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Reprofiling Product Solution and Service
Table 21. Date of Enter into Drug Reprofiling Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Drug Reprofiling Revenue Market Share by Type (2016-2021)
Table 25. Global Drug Reprofiling Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Drug Reprofiling Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Drug Reprofiling Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Drug Reprofiling Revenue Market Share by Application (2016-2021)
Table 29. Global Drug Reprofiling Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Drug Reprofiling Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Drug Reprofiling Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Drug Reprofiling Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Drug Reprofiling Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Drug Reprofiling Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Drug Reprofiling Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Drug Reprofiling Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Drug Reprofiling Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Drug Reprofiling Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Drug Reprofiling Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Drug Reprofiling Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Drug Reprofiling Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drug Reprofiling Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drug Reprofiling Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drug Reprofiling Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Drug Reprofiling Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Drug Reprofiling Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Drug Reprofiling Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Drug Reprofiling Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Drug Reprofiling Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Drug Reprofiling Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Drug Reprofiling Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Drug Reprofiling Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drug Reprofiling Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drug Reprofiling Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drug Reprofiling Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Drug Reprofiling Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Drug Reprofiling Product
Table 64. Novartis AG Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Abbott Healthcare Company Details
Table 67. Abbott Healthcare Business Overview
Table 68. Abbott Healthcare Drug Reprofiling Product
Table 69. Abbott Healthcare Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 70. Abbott Healthcare Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Drug Reprofiling Product
Table 74. Pfizer Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Drug Reprofiling Product
Table 79. Johnson & Johnson Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Hoffmann-La Roche Company Details
Table 82. Hoffmann-La Roche Business Overview
Table 83. Hoffmann-La Roche Drug Reprofiling Product
Table 84. Hoffmann-La Roche Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 85. Hoffmann-La Roche Recent Development
Table 86. Sandoz Company Details
Table 87. Sandoz Business Overview
Table 88. Sandoz Drug Reprofiling Product
Table 89. Sandoz Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 90. Sandoz Recent Development
Table 91. Mylan Inc. Company Details
Table 92. Mylan Inc. Business Overview
Table 93. Mylan Inc. Drug Reprofiling Product
Table 94. Mylan Inc. Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 95. Mylan Inc. Recent Development
Table 96. Teva Pharmaceuticals Company Details
Table 97. Teva Pharmaceuticals Business Overview
Table 98. Teva Pharmaceuticals Revenue in Drug Reprofiling Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Reprofiling Market Share by Type: 2020 VS 2027
Figure 2. Orally Features
Figure 3. Intravenously Features
Figure 4. Global Drug Reprofiling Market Share by Application: 2020 VS 2027
Figure 5. Central Nervous Disorders Case Studies
Figure 6. Cardiovascular Disorders Case Studies
Figure 7. Oncology Case Studies
Figure 8. others Case Studies
Figure 9. Drug Reprofiling Report Years Considered
Figure 10. Global Drug Reprofiling Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Drug Reprofiling Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drug Reprofiling Market Share by Regions: 2020 VS 2027
Figure 13. Global Drug Reprofiling Market Share by Regions (2022-2027)
Figure 14. Global Drug Reprofiling Market Share by Players in 2020
Figure 15. Global Top Drug Reprofiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Reprofiling as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Drug Reprofiling Revenue in 2020
Figure 17. Global Drug Reprofiling Revenue Market Share by Type (2016-2021)
Figure 18. Global Drug Reprofiling Revenue Market Share by Type (2022-2027)
Figure 19. North America Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Drug Reprofiling Market Share by Type (2016-2027)
Figure 21. North America Drug Reprofiling Market Share by Application (2016-2027)
Figure 22. North America Drug Reprofiling Market Share by Country (2016-2027)
Figure 23. United States Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Reprofiling Market Share by Type (2016-2027)
Figure 27. Europe Drug Reprofiling Market Share by Application (2016-2027)
Figure 28. Europe Drug Reprofiling Market Share by Country (2016-2027)
Figure 29. Germany Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Reprofiling Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Drug Reprofiling Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Drug Reprofiling Market Share by Region (2016-2027)
Figure 39. China Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Reprofiling Market Share by Type (2016-2027)
Figure 47. Latin America Drug Reprofiling Market Share by Application (2016-2027)
Figure 48. Latin America Drug Reprofiling Market Share by Country (2016-2027)
Figure 49. Mexico Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Reprofiling Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Drug Reprofiling Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Drug Reprofiling Market Share by Country (2016-2027)
Figure 55. Turkey Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Drug Reprofiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis AG Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 59. Abbott Healthcare Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 62. Hoffmann-La Roche Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 63. Sandoz Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 64. Mylan Inc. Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Drug Reprofiling Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の小売薬市場規模・現状・予測（2021年-2027年）

Global Retail Drug Market Size, Status and Forecast 2021-2027
QYR2104Z5016 2021年4月 96Pages
QYResearch社発行の本調査資料では、小売薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリック医薬品、OTC医薬品、その他）、用途別市場規模（病院、診療所、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年）

Global Nanotechnology in Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z4016 2021年4月 91Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーにおけるナノテクノロジーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標的化送達、薬剤パッケージ）、用途別市場規模（がん、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年）

Global Allergy Rhinitis Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0246 2021年4月 95Pages
QYResearch社発行の本調査資料では、アレルギー性鼻炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、スプレー）、用途別市場規模（病院、クリニック、医療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repurposing Market Size, Status and Forecast 2021-2027
QYR2104Z1992 2021年4月 96Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、中枢神経系疾患、神経変性疾患、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年）

Global Drug of Abuse Testing Services Market Size, Status and Forecast 2021-2027
QYR2104Z1989 2021年4月 92Pages
QYResearch社発行の本調査資料では、薬物乱用検査サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルコール、大麻、コカイン、オピオイド、アンフェタミン、LSD、その他）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模...

世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年）

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repositioning Market Size, Status and Forecast 2021-2027
QYR2104Z1990 2021年4月 98Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Drug Discovery Market Size, Status and Forecast 2021-2027
QYR2104Z1983 2021年4月 99Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小分子薬、生物製剤）、用途別市場規模（研究所、製薬会社、バイオテクノロジー会社）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の糖尿病黄斑浮腫治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Macular Edema Drug Market Size, Status and Forecast 2021-2027
QYR2104Z1833 2021年4月 99Pages
QYResearch社発行の本調査資料では、糖尿病黄斑浮腫治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（硝子体内注射、硝子体内インプラント）、用途別市場規模（抗VEGF、コルチコステロイド、その他）、主要地域別市場規模（北米、アメリカ、...

世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年）

Global Pain Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z4405 2021年4月 95Pages
QYResearch社発行の本調査資料では、鎮痛剤デリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別市場規模（腫瘍、神経障害、肺疾患、ホルモン障害、その他...

世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年） Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics Market Analysis and Insights: Global Central Nervous System Disorders …
世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Repositioning Market The global Drug Repositioning market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…
世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
世界の小分子創薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small-Molecule Drug Discovery Market The global Small-Molecule Drug Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…